Ousia Pharma ApS: Financial statements 2025
CVR: 43055909
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Ousia Pharma ApS (CVR 43055909) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -10,204,929 and a net result of DKK -12,777,761 compared with DKK -5,348,579 the year before. Equity in the 2025 report amounted to DKK 11,818,220. The solvency ratio was 94.6%. The company had 8 employees in the financial year.
- Gross Profit
- DKK -10,204,929
- Profit/Loss
- DKK -12,777,761
- Equity
- DKK 11,818,220
- Total Assets
- DKK 12,497,918
- Employees
- 8
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -10.2 mio. | -12.8 mio. | 11.8 mio. | 8 |
| 2024 | - | -3.7 mio. | -5.3 mio. | -10.1 mio. | 6 |
| 2023 | - | -2.2 mio. | -3.7 mio. | -4.7 mio. | 5 |
| 2022 | - | -645 t. | -904 t. | -864 t. | 3 |
Official annual report
How creditworthy is Ousia Pharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Ousia Pharma ApS has published its annual report for 2024. Gross profit came to DKK -3,655,869, and the net result was DKK -5,348,579.
As of March 27, 2025, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Ousia Pharma ApS.
As of March 27, 2025, Menelas Nicolas Pangalos has joined the board of directors of Ousia Pharma ApS.
As of March 27, 2025, Otello Stampacchia has joined the board of directors of Ousia Pharma ApS.
As of March 27, 2025, Margareta Elisabeth Björk has joined the board of directors of Ousia Pharma ApS.
As of March 27, 2025, Mikael Søndergaard Thomsen has left the board of directors of Ousia Pharma ApS.
As of March 27, 2025, Jeppe Ragnar Andersen has left the board of directors of Ousia Pharma ApS.
As of March 27, 2025, Morten Peltola Toft has left the board of directors of Ousia Pharma ApS.
As of March 27, 2025, Jonas Odgaard Petersen has left the board of directors of Ousia Pharma ApS.
As of March 27, 2025, Anders Bue Klein has left the board of directors of Ousia Pharma ApS.
About Ousia Pharma ApS
Ousia Pharma ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2022. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Ouisa Pharma ApS. The management consists of Anders Bue Klein, Christoffer Clemmensen and Jonas Odgaard Petersen. The board consists of Gaurav Gupta (chair), Menelas Nicolas Pangalos, Otello Stampacchia and Ramesh Rajanikant Bhatt. The company is owned by JLSa2 Therapeutics, Inc.. The company has 8 employees (2026). In 2025, the company reported a gross profit of DKK -10,204,929 and a net result of DKK -12,777,761 compared with DKK -5,348,579 the year before. Equity in the 2025 report amounted to DKK 11,818,220.